Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. 

Biotechnology

Aro Biotherapeutics

Susan Dillon

Jeffrey Staiger

Zhanna Druzina

Liz McKee Anderson

Mark Laurenzi

Karyn O’Neil

Sukumar Sakamuri

The Scientific Research Team at Aro Biotherapeutics is responsible for advancing the company’s proprietary protein technology, Centyrins, through innovative research and development. This team of experts conducts studies in various disciplines, including biology, immunology, RNA biology, and protein engineering, to discover and optimize tissue-targeted genetic medicines aimed at unlocking therapeutic potential for genetic disorders. Their collaborative efforts drive scientific exploration and translate findings into viable treatment options.

Scientific Research Team

Management and Administration Team

Leadership Team

Scientific Research Team

About

Team members

Other teams at Aro Biotherapeutics

Management and Administration Team

Leadership Team